China Alzheimers Disease Diagnostics Market Size & Outlook
- Clinical Diagnostics
- In Vitro Diagnostics
- Alzheimers Disease Diagnostics Market Outlook
- In Vitro Diagnostics
Global Market
Related Markets
Ask a question about the alzheimers disease diagnostics market
China alzheimers disease diagnostics market highlights
- The China alzheimers disease diagnostics market generated a revenue of USD 355.7 million in 2025 and is expected to reach USD 873.0 million by 2033.
- The China market is expected to grow at a CAGR of 11.9% from 2026 to 2033.
- In terms of segment, imaging techniques was the largest revenue generating diagnostic technique in 2025.
- Biomarkers is the most lucrative diagnostic technique segment registering the fastest growth during the forecast period.
Alzheimers disease diagnostics market data book summary
| Market revenue in 2025 | USD 355.7 million |
| Market revenue in 2033 | USD 873.0 million |
| Growth rate | 11.9% (CAGR from 2026 to 2033) |
| Largest segment | Imaging techniques |
| Fastest growing segment | Biomarkers |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Biomarkers, Imaging Techniques, Genetic Testing, Cognitive Assessment Tests |
| Key market players worldwide | Quest Diagnostics Inc, Sysmex Corp, Lantheus Holdings Inc, Siemens Healthineers AG ADR, F. Hoffmann-La Roche Ltd., Quanterix, Fujirebio Diagnostics, C2N Diagnostics |
Other key industry trends
- In terms of revenue, China accounted for 3.9% of the global alzheimers disease diagnostics market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Asia Pacific, China alzheimers disease diagnostics market is projected to lead the regional market in terms of revenue in 2033.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 600.2 million by 2033.
The market in China is anticipated to grow swiftly due to a rising incidence of Alzheimer’s disease in the younger population. In China, the prevalence of Alzheimer is becoming a major issue, thus driving the demand for early diagnosis, treatment, and supportive care services.
Rising stress levels, poor diet, lack of physical activity, and increased exposure to pollution contribute to early-onset neurodegenerative conditions. For instance, according to NDTV Convergence Limited, 2025, According to the South China Morning Post, a 19-year-old Chinese man has been diagnosed with Alzheimer’s disease, making him the youngest person to ever be diagnosed with the illness.
Nearly all Alzheimer’s patients under 30 have pathogenic gene alterations, the doctors said. The 21-yearold with the gene mutation was the youngest individual ever diagnosed with Alzheimer’s disease.
No credit card required*
Publish Date: Dec 17, 2025
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Alzheimers Disease Diagnostics Market Scope
Alzheimers Disease Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Siemens Healthineers AG ADR | View profile | 71,400 | Siemensstr. 3, Forchheim, BY, Germany, 91301 | www.siemens-healthineers.com |
| Quest Diagnostics Inc | View profile | 48,000 | 500 Plaza Drive, Secaucus, NJ, United States, 07094 | www.questdiagnostics.com |
| Sysmex Corp | View profile | 10,448 | 1-5-1 Wakinohara-Kaigandori, Chuo-ku, Hyogo Prefecture, Kobe, Japan, 6510073 | www.sysmex.co.jp |
| Lantheus Holdings Inc | View profile | 834 | 201 Burlington Road, South Building, Bedford, MA, United States, 01730 | www.lantheus.com |
| F. Hoffmann-La Roche Ltd. | View profile | - | - | - |
| C2N Diagnostics | View profile | 11-50 | Saint Louis, Missouri, United States, North America | c2n.com/ |
| Fujirebio Diagnostics | View profile | 5001-10000 | Malvern, Pennsylvania, United States, North America | www.fdi.com/ |
| Quanterix | View profile | 251-500 | Billerica, Massachusetts, United States, North America | www.quanterix.com |
China Alzheimers Disease Diagnostics Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Alzheimers Disease Diagnostics Market Outlook will help companies and investors design strategic landscapes.
Imaging Techniques was the largest segment with a revenue share of 45.04% in 2025.
Horizon Databook has segmented the China alzheimers disease diagnostics market based on biomarkers, imaging techniques, genetic testing, cognitive assessment tests covering the revenue growth of each sub-segment from 2021 to 2033.
The market in China is anticipated to grow swiftly due to a rising incidence of Alzheimer’s disease in the younger population. In China, the prevalence of Alzheimer is becoming a major issue, thus driving the demand for early diagnosis, treatment, and supportive care services.
Rising stress levels, poor diet, lack of physical activity, and increased exposure to pollution contribute to early-onset neurodegenerative conditions. For instance, according to NDTV Convergence Limited, 2025, According to the South China Morning Post, a 19-year-old Chinese man has been diagnosed with Alzheimer’s disease, making him the youngest person to ever be diagnosed with the illness.
Nearly all Alzheimer’s patients under 30 have pathogenic gene alterations, the doctors said. The 21-yearold with the gene mutation was the youngest individual ever diagnosed with Alzheimer’s disease.
- China Alzheimers Disease Diagnostics Market Diagnostic Technique Outlook (Revenue, USD Million , 2021-2033)
- Biomarkers
- Imaging Techniques
- Genetic Testing
- Cognitive Assessment Tests
- China Alzheimers Disease Diagnostics Market Type Outlook (Revenue, USD Million , 2021-2033)
- Triage
- Diagnosis
- Screening
- China Alzheimers Disease Diagnostics Market End Use Outlook (Revenue, USD Million , 2021-2033)
- Hospitals
- Diagnostic Laboratories
- Academic and Research Institutes
Reasons to subscribe to Alzheimers Disease Diagnostics Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Alzheimers Disease Diagnostics Market Outlook databook
- Our clientele includes a mix of Alzheimers Disease Diagnostics Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China Alzheimers Disease Diagnostics Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into China Alzheimers Disease Diagnostics Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
China Alzheimers Disease Diagnostics Market, 2021-2033 (US$M)
China alzheimers disease diagnostics market statistics, by diagnostic technique, 2021-2033 (US$M)
